BOSTON SCIENTIFIC CORP
For the period ended Sep 30, 2025. Filed Nov 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 3, 2025
BSX$44.70+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets (Unaudited)
| As of | ||
|---|---|---|
| (in millions, except share and per share data) | September 30, 2025 | December 31, 2024 |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,275 | $414 |
| Trade accounts receivable, net | 2,828 | 2,558 |
| Inventories | 2,921 | 2,810 |
| Prepaid income taxes | 310 | 307 |
| Other current assets | 701 | 831 |
| Total current assets | 8,035 | 6,920 |
| Property, plant and equipment, net | 3,795 | 3,294 |
| Goodwill | 18,214 | 17,089 |
| Other intangible assets, net | 7,162 | 6,684 |
| Deferred tax assets | 3,669 | 3,655 |
| Other long-term assets | 1,832 | 1,754 |
| TOTAL ASSETS | $42,707 | $39,395 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Current debt obligations | $483 | $1,778 |
| Accounts payable | 1,002 | 960 |
| Accrued expenses | 2,981 | 2,773 |
| Other current liabilities | 862 | 887 |
| Total current liabilities | 5,328 | 6,399 |
| Long-term debt | 11,117 | 8,968 |
| Deferred tax liabilities | 242 | 155 |
| Other long-term liabilities | 2,390 | 1,870 |
| Commitments and contingencies | ||
| Stockholders’ equity | ||
| Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of September 30, 2025 and December 31, 2024 | — | — |
| Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,745,573,129 shares issued as of September 30, 2025 and 1,737,846,196 shares issued as of December 31, 2024 | 17 | 17 |
| Treasury stock, at cost - 263,289,848 shares as of September 30, 2025 and December 31, 2024 | (2,251) | (2,251) |
| Additional paid-in capital | 21,419 | 21,056 |
| Retained earnings | 4,899 | 2,673 |
| Accumulated other comprehensive income (loss), net of tax | (689) | 275 |
| Total stockholders’ equity | 23,394 | 21,770 |
| Noncontrolling interests | 236 | 233 |
| Total equity | 23,630 | 22,003 |
| TOTAL LIABILITIES AND EQUITY | $42,707 | $39,395 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.